Earnings Per Share

A reconciliation between the basic and diluted earnings per share computations (in thousands, except per share amounts) is as follow:



For the Three Months Ended September 30, 2018	Loss (Numerator)			Shares (Denominator)	Per Share Amount
BASIC EPS
Net loss available to common stockholders	$	(4,979	)	25,587	$	(0.19	)
Stock options	—			—
Attributable to participating securities	—			—
DILUTED EPS	$	(4,979	)	25,587	$	(0.19	)

For the Nine Months Ended September 30, 2018	Loss (Numerator)			Shares (Denominator)	Per Share Amount
BASIC EPS
Net loss available to common stockholders	$	(9,802	)	25,565	$	(0.38	)
Stock options	—			—
Attributable to participating securities	—			—
DILUTED EPS	$	(9,802	)	25,565	$	(0.38	)

For the Three Months Ended September 30, 2017	Loss (Numerator)			Shares (Denominator)	Per Share Amount
BASIC EPS
Net loss available to common stockholders	$	(3,085	)	21,230	$	(0.15	)
Stock options	—			—
Attributable to participating securities	—			—
DILUTED EPS	$	(3,085	)	21,230	$	(0.15	)

For the Nine Months Ended September 30, 2017	Loss (Numerator)			Shares (Denominator)	Per Share Amount
BASIC EPS
Net loss available to common stockholders	$	(11,387	)	21,222	$	(0.54	)
Stock options	—			—
Attributable to participating securities	—			—
DILUTED EPS	$	(11,387	)	21,222	$	(0.54	)

An aggregate of 1.9 million and 1.4 million shares of common stock representing options to purchase common stock and unvested shares of restricted common stock and common shares issuable upon the assumed conversion of the Series B Preferred Stock totaling 1.3 million shares were not included in the computation of diluted earnings per share for the three month periods ended September 30, 2018 and 2017, respectively, because the inclusion would have been anti-dilutive as a result of the net loss reported for such periods.

An aggregate of 2.0 million and 1.4 million shares of common stock representing options to purchase common stock and unvested shares of restricted common stock and common shares issuable upon the assumed conversion of the Series B Preferred Stock totaling 1.3 million shares were not included in the computation of diluted earnings per share for the nine month periods ended September 30, 2018 and 2017, respectively, because the inclusion would have been anti-dilutive as a result of the net loss reported for such periods.